Ad is loading...
LRMR
Price
$6.16
Change
+$0.03 (+0.49%)
Updated
Nov 22 closing price
109 days until earnings call
ROIV
Price
$12.53
Change
+$0.71 (+6.01%)
Updated
Nov 22 closing price
86 days until earnings call
Ad is loading...

LRMR vs ROIV

Header iconLRMR vs ROIV Comparison
Open Charts LRMR vs ROIVBanner chart's image
Larimar Therapeutics
Price$6.16
Change+$0.03 (+0.49%)
Volume$402.09K
CapitalizationN/A
Roivant Sciences
Price$12.53
Change+$0.71 (+6.01%)
Volume$11.36M
CapitalizationN/A
LRMR vs ROIV Comparison Chart
Loading...
LRMR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
LRMR vs. ROIV commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LRMR is a Hold and ROIV is a StrongBuy.

COMPARISON
Comparison
Nov 23, 2024
Stock price -- (LRMR: $6.16 vs. ROIV: $12.53)
Brand notoriety: LRMR and ROIV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LRMR: 52% vs. ROIV: 174%
Market capitalization -- LRMR: $393.05M vs. ROIV: $9.12B
LRMR [@Biotechnology] is valued at $393.05M. ROIV’s [@Biotechnology] market capitalization is $9.12B. The market cap for tickers in the [@Biotechnology] industry ranges from $450.11B to $0. The average market capitalization across the [@Biotechnology] industry is $2.6B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LRMR’s FA Score shows that 1 FA rating(s) are green whileROIV’s FA Score has 1 green FA rating(s).

  • LRMR’s FA Score: 1 green, 4 red.
  • ROIV’s FA Score: 1 green, 4 red.
According to our system of comparison, ROIV is a better buy in the long-term than LRMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LRMR’s TA Score shows that 4 TA indicator(s) are bullish while ROIV’s TA Score has 5 bullish TA indicator(s).

  • LRMR’s TA Score: 4 bullish, 6 bearish.
  • ROIV’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ROIV is a better buy in the short-term than LRMR.

Price Growth

LRMR (@Biotechnology) experienced а -7.92% price change this week, while ROIV (@Biotechnology) price change was +11.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.38%. For the same industry, the average monthly price growth was -4.87%, and the average quarterly price growth was +4.35%.

Reported Earning Dates

LRMR is expected to report earnings on Mar 12, 2025.

ROIV is expected to report earnings on Feb 17, 2025.

Industries' Descriptions

@Biotechnology (+2.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROIV($9.12B) has a higher market cap than LRMR($393M). LRMR YTD gains are higher at: 35.385 vs. ROIV (11.576). ROIV has higher annual earnings (EBITDA): 4.15B vs. LRMR (-73.44M). ROIV has more cash in the bank: 5.39B vs. LRMR (204M). LRMR has less debt than ROIV: LRMR (5.36M) vs ROIV (52.7M). ROIV has higher revenues than LRMR: ROIV (129M) vs LRMR (0).
LRMRROIVLRMR / ROIV
Capitalization393M9.12B4%
EBITDA-73.44M4.15B-2%
Gain YTD35.38511.576306%
P/E RatioN/A2.26-
Revenue0129M-
Total Cash204M5.39B4%
Total Debt5.36M52.7M10%
FUNDAMENTALS RATINGS
LRMR: Fundamental Ratings
LRMR
OUTLOOK RATING
1..100
70
VALUATION
overvalued / fair valued / undervalued
1..100
29
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LRMRROIV
RSI
ODDS (%)
Bearish Trend 2 days ago
89%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
67%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
62%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
63%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
64%
Advances
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
72%
Declines
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 6 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
67%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
63%
View a ticker or compare two or three
Ad is loading...
LRMR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SFYF42.170.31
+0.75%
SoFi Social 50 ETF
EFG98.940.57
+0.58%
iShares MSCI EAFE Growth ETF
SEIQ35.950.19
+0.53%
SEI Enhanced US Large Cap Qual Fac ETF
DIVI30.580.09
+0.30%
Franklin Intl Core Div Tlt Idx ETF
MJUS0.96-0.03
-2.93%
Amplify U.S. Alternative Harvest ETF

LRMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LRMR has been loosely correlated with SVRA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if LRMR jumps, then SVRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LRMR
1D Price
Change %
LRMR100%
+0.49%
SVRA - LRMR
42%
Loosely correlated
+3.70%
IDYA - LRMR
40%
Loosely correlated
+0.71%
ROIV - LRMR
39%
Loosely correlated
+6.01%
ABSI - LRMR
37%
Loosely correlated
+0.39%
VIR - LRMR
36%
Loosely correlated
+2.45%
More

ROIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
+6.01%
IMVT - ROIV
57%
Loosely correlated
+1.24%
ARGX - ROIV
44%
Loosely correlated
+1.54%
PGEN - ROIV
43%
Loosely correlated
-0.03%
AXON - ROIV
43%
Loosely correlated
+0.90%
RARE - ROIV
42%
Loosely correlated
+2.65%
More